ArticleInvestigational new drugs2012

Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination.

Michael Millward et al.PubMed ↗Publisher ↗

No numbers read from the abstract.